<p>PharVision Advisers LLC 在最近向證券交易委員會（SEC）提交的 13F 文件中表示，在第四季度購買了 Pediatrix Medical Group, Inc.（紐約證券交易所代碼：MD - 免費報告）的新股份。該基金購買了 18,644 股公司股票，價值約為 245,000 美元。</p>
<ul>
<li>美敦力：穩定與創新的股息貴族</li>
</ul>
<p>其他一些大型投資者也對該公司的持股進行了調整。野村資產管理有限公司在第四季度將其在 Pediatrix Medical Group 的持股增加了 95.3%。野村資產管理有限公司現在擁有 2,500 股公司股票，價值 33,000 美元，此前在該期間又購買了 1,220 股。Parkside Financial Bank &amp; Trust 在第四季度將其在 Pediatrix Medical Group 的持股增加了 36.1%。Parkside Financial Bank &amp; Trust 現在擁有 3,919 股公司股票，價值 51,000 美元，此前在該期間又購買了 1,040 股。AlphaQuest LLC 在第四季度將其在 Pediatrix Medical Group 的持股增加了 65.9%。AlphaQuest LLC 現在擁有 5,066 股公司股票，價值 66,000 美元，此前在該期間又購買了 2,012 股。Smartleaf Asset Management LLC 在第四季度將其在 Pediatrix Medical Group 的持股增加了 750.9%。Smartleaf Asset Management LLC 現在擁有 6,901 股公司股票，價值 91,000 美元，此前在該期間又購買了 6,090 股。最後，Tower Research Capital LLC TRC 在第四季度將其在 Pediatrix Medical Group 的持股增加了 218.0%。Tower Research Capital LLC TRC 現在擁有 7,445 股公司股票，價值 98,000 美元，此前在該期間又購買了 5,104 股。機構投資者和對沖基金持有公司 97.71% 的股票。</p>
<h2>分析師設定新目標價</h2>
<p>一些股票研究分析師最近對 MD 股票發佈了報告。瑞銀集團將 Pediatrix Medical Group 的目標價從 18.50 美元下調至 16.00 美元，並在 5 月 12 日的研究報告中對該公司給予了 “中性” 評級。Truist Financial 將 Pediatrix Medical Group 的目標價從 18.00 美元下調至 16.00 美元，並在 4 月 11 日的研究報告中對該公司給予了 “持有” 評級。最後，麥格理將 Pediatrix Medical Group 的目標價從 19.00 美元上調至 20.00 美元，並在 5 月 8 日的研究報告中給予了該公司 “跑贏大盤” 的評級。四位股票研究分析師對該股票給予了持有評級，三位給予了買入評級。根據 MarketBeat.com 的數據，該股票目前的共識評級為 “持有”，平均目標價為 16.67 美元。</p>
<ul>
<li>MarketBeat 週迴顧 – 02/17 - 02/21</li>
</ul>
<p><strong>獲取我們最新的 MD 股票分析</strong></p>
<h2>Pediatrix Medical Group 股票下跌 7.9%</h2>
<p>紐約證券交易所 MD 的股票在週五開盤價為 13.98 美元。該公司的市值為 12 億美元，市盈率為 -11.65，市盈增長比率為 1.74，貝塔係數為 1.26。該公司的流動比率為 1.60，速動比率為 1.42，債務股本比率為 0.81。Pediatrix Medical Group, Inc. 的一年最低價為 6.62 美元，一年最高價為 17.67 美元。該公司的 50 日移動平均線為 13.78 美元，200 日移動平均線為 14.12 美元。</p>
<ul>
<li>美敦力的擴張勢頭增強——市場轉變的時機？</li>
</ul>
<p>Pediatrix Medical Group（紐約證券交易所：MD - 獲取免費報告）最近在 5 月 6 日發佈了其財報。該公司報告季度每股收益（EPS）為 0.33 美元，超出市場共識預期的 0.25 美元，超出幅度為 0.08 美元。該公司季度收入為 4.5836 億美元，而分析師預期為 4.5144 億美元。Pediatrix Medical Group 的淨利潤率為 -4.92%，股本回報率為 15.47%。該公司季度收入同比下降 7.4%。去年同期，該公司每股收益為 0.20 美元。股票分析師預計 Pediatrix Medical Group, Inc. 今年將發佈 1.38 美元的每股收益。</p>
<h2>關於 Pediatrix Medical Group</h2>
<p>（免費報告）</p>
<p>Pediatrix Medical Group, Inc. 及其子公司在美國提供新生兒、母胎、兒科心臟病學及其他兒科專科護理服務。它提供新生兒護理服務，包括通過新生兒醫學專科醫生、新生兒護士執業者和其他兒科臨牀醫生在醫院特定病房內對早產或有併發症的嬰兒進行臨牀護理。</p>
<h2>進一步閲讀</h2>
<ul>
<li>我們更看好的五隻股票而非 Pediatrix Medical Group</li>
<li>澳大利亞證券交易所（ASX）是什麼</li>
<li>Joby 股票的波動：近期下跌的原因是什麼？</li>
<li>三隻小型股具有巨大的回報潛力</li>
<li>為什麼嘉年華可能是終極非科技增長股</li>
<li>三隻最佳金融科技股票以提升投資組合</li>
<li>超級微型計算機股票在沙特訂單中開闢新路徑</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1E?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1E"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Pediatrix Medical Group 嗎？</h2>
<p>在考慮 Pediatrix Medical Group 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦購買，以便在更廣泛的市場注意到之前……而 Pediatrix Medical Group 並不在名單上。</p>
<p>雖然 Pediatrix Medical Group 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

<p>PharVision Advisers LLC 在 Pediatrix Medical Group, Inc. (NYSE:MD) 中獲得了新的股份，在第四季度購買了價值約 245,000 美元的 18,644 股。其他機構投資者也增加了在該公司的持倉。分析師對該股票設定了一致的 “持有” 評級，平均目標價為 16.67 美元。Pediatrix Medical Group 報告了上一季度每股收益為 0.33 美元，超出預期，但其收入同比下降了 7.4%</p>

<p>PharVision Advisers LLC purchased a new stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 18,644 shares of the company's stock, valued at approximately $245,000.</p>
<div class="lb-trans"><p>PharVision Advisers LLC 在最近向證券交易委員會（SEC）提交的 13F 文件中表示，在第四季度購買了 Pediatrix Medical Group, Inc.（紐約證券交易所代碼：MD - 免費報告）的新股份。該基金購買了 18,644 股公司股票，價值約為 245,000 美元。</p>
</div><ul>
<li>Medtronic: A Dividend Aristocrat With Stability and Innovation</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力：穩定與創新的股息貴族</li>
</ul>
</div><p>A number of other large investors have also made changes to their positions in the company. Nomura Asset Management Co. Ltd. increased its stake in Pediatrix Medical Group by 95.3% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock valued at $33,000 after buying an additional 1,220 shares during the period. Parkside Financial Bank &amp; Trust boosted its holdings in shares of Pediatrix Medical Group by 36.1% during the 4th quarter. Parkside Financial Bank &amp; Trust now owns 3,919 shares of the company's stock worth $51,000 after buying an additional 1,040 shares during the period. AlphaQuest LLC boosted its holdings in shares of Pediatrix Medical Group by 65.9% during the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock worth $66,000 after buying an additional 2,012 shares during the period. Smartleaf Asset Management LLC boosted its holdings in Pediatrix Medical Group by 750.9% in the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock valued at $91,000 after purchasing an additional 6,090 shares during the period. Finally, Tower Research Capital LLC TRC boosted its holdings in Pediatrix Medical Group by 218.0% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock valued at $98,000 after purchasing an additional 5,104 shares during the period. Institutional investors and hedge funds own 97.71% of the company's stock.</p>
<div class="lb-trans"><p>其他一些大型投資者也對該公司的持股進行了調整。野村資產管理有限公司在第四季度將其在 Pediatrix Medical Group 的持股增加了 95.3%。野村資產管理有限公司現在擁有 2,500 股公司股票，價值 33,000 美元，此前在該期間又購買了 1,220 股。Parkside Financial Bank &amp; Trust 在第四季度將其在 Pediatrix Medical Group 的持股增加了 36.1%。Parkside Financial Bank &amp; Trust 現在擁有 3,919 股公司股票，價值 51,000 美元，此前在該期間又購買了 1,040 股。AlphaQuest LLC 在第四季度將其在 Pediatrix Medical Group 的持股增加了 65.9%。AlphaQuest LLC 現在擁有 5,066 股公司股票，價值 66,000 美元，此前在該期間又購買了 2,012 股。Smartleaf Asset Management LLC 在第四季度將其在 Pediatrix Medical Group 的持股增加了 750.9%。Smartleaf Asset Management LLC 現在擁有 6,901 股公司股票，價值 91,000 美元，此前在該期間又購買了 6,090 股。最後，Tower Research Capital LLC TRC 在第四季度將其在 Pediatrix Medical Group 的持股增加了 218.0%。Tower Research Capital LLC TRC 現在擁有 7,445 股公司股票，價值 98,000 美元，此前在該期間又購買了 5,104 股。機構投資者和對沖基金持有公司 97.71% 的股票。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析師設定新目標價</h2>
</div><p>A number of equities research analysts recently issued reports on MD shares. UBS Group dropped their target price on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a &#34;neutral&#34; rating for the company in a research report on Monday, May 12th. Truist Financial lowered their price objective on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a &#34;hold&#34; rating for the company in a research report on Friday, April 11th. Finally, Macquarie raised their price objective on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the company an &#34;outperform&#34; rating in a research report on Thursday, May 8th. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of &#34;Hold&#34; and an average price target of $16.67.</p>
<div class="lb-trans"><p>一些股票研究分析師最近對 MD 股票發佈了報告。瑞銀集團將 Pediatrix Medical Group 的目標價從 18.50 美元下調至 16.00 美元，並在 5 月 12 日的研究報告中對該公司給予了 “中性” 評級。Truist Financial 將 Pediatrix Medical Group 的目標價從 18.00 美元下調至 16.00 美元，並在 4 月 11 日的研究報告中對該公司給予了 “持有” 評級。最後，麥格理將 Pediatrix Medical Group 的目標價從 19.00 美元上調至 20.00 美元，並在 5 月 8 日的研究報告中給予了該公司 “跑贏大盤” 的評級。四位股票研究分析師對該股票給予了持有評級，三位給予了買入評級。根據 MarketBeat.com 的數據，該股票目前的共識評級為 “持有”，平均目標價為 16.67 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 02/17 - 02/21</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週迴顧 – 02/17 - 02/21</li>
</ul>
</div><p><strong>Get Our Latest Stock Analysis on MD</strong></p>
<div class="lb-trans"><p><strong>獲取我們最新的 MD 股票分析</strong></p>
</div><h2>Pediatrix Medical Group Stock Down 7.9%</h2>
<div class="lb-trans"><h2>Pediatrix Medical Group 股票下跌 7.9%</h2>
</div><p>Shares of NYSE MD opened at $13.98 on Friday. The firm has a market capitalization of $1.20 billion, a PE ratio of -11.65, a price-to-earnings-growth ratio of 1.74 and a beta of 1.26. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group, Inc. has a 1 year low of $6.62 and a 1 year high of $17.67. The firm's 50-day moving average is $13.78 and its 200-day moving average is $14.12.</p>
<div class="lb-trans"><p>紐約證券交易所 MD 的股票在週五開盤價為 13.98 美元。該公司的市值為 12 億美元，市盈率為 -11.65，市盈增長比率為 1.74，貝塔係數為 1.26。該公司的流動比率為 1.60，速動比率為 1.42，債務股本比率為 0.81。Pediatrix Medical Group, Inc. 的一年最低價為 6.62 美元，一年最高價為 17.67 美元。該公司的 50 日移動平均線為 13.78 美元，200 日移動平均線為 14.12 美元。</p>
</div><ul>
<li>Medtronic’s Expansion Gains Momentum—Time for a Market Shift?</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力的擴張勢頭增強——市場轉變的時機？</li>
</ul>
</div><p>Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.08. The company had revenue of $458.36 million for the quarter, compared to analyst estimates of $451.44 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The company's revenue for the quarter was down 7.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.20 EPS. Equities analysts expect that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.</p>
<div class="lb-trans"><p>Pediatrix Medical Group（紐約證券交易所：MD - 獲取免費報告）最近在 5 月 6 日發佈了其財報。該公司報告季度每股收益（EPS）為 0.33 美元，超出市場共識預期的 0.25 美元，超出幅度為 0.08 美元。該公司季度收入為 4.5836 億美元，而分析師預期為 4.5144 億美元。Pediatrix Medical Group 的淨利潤率為 -4.92%，股本回報率為 15.47%。該公司季度收入同比下降 7.4%。去年同期，該公司每股收益為 0.20 美元。股票分析師預計 Pediatrix Medical Group, Inc. 今年將發佈 1.38 美元的每股收益。</p>
</div><h2>About Pediatrix Medical Group</h2>
<div class="lb-trans"><h2>關於 Pediatrix Medical Group</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.</p>
<div class="lb-trans"><p>Pediatrix Medical Group, Inc. 及其子公司在美國提供新生兒、母胎、兒科心臟病學及其他兒科專科護理服務。它提供新生兒護理服務，包括通過新生兒醫學專科醫生、新生兒護士執業者和其他兒科臨牀醫生在醫院特定病房內對早產或有併發症的嬰兒進行臨牀護理。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than Pediatrix Medical Group</li>
<li>What is the Australian Securities Exchange (ASX)</li>
<li>Turbulence for Joby Shares: What's Behind the Recent Dip?</li>
<li>3 Small Caps With Big Return Potential</li>
<li>Why Carnival Could Be the Ultimate Non-Tech Growth Stock</li>
<li>3 Best Fintech Stocks for a Portfolio Boost</li>
<li>Super Micro Computer Stock Clears New Path Higher on Saudi Orders</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票而非 Pediatrix Medical Group</li>
<li>澳大利亞證券交易所（ASX）是什麼</li>
<li>Joby 股票的波動：近期下跌的原因是什麼？</li>
<li>三隻小型股具有巨大的回報潛力</li>
<li>為什麼嘉年華可能是終極非科技增長股</li>
<li>三隻最佳金融科技股票以提升投資組合</li>
<li>超級微型計算機股票在沙特訂單中開闢新路徑</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1E" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=MD"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Pediatrix Medical Group Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Pediatrix Medical Group 嗎？</h2>
</div><p>Before you consider Pediatrix Medical Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Pediatrix Medical Group 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pediatrix Medical Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦購買，以便在更廣泛的市場注意到之前……而 Pediatrix Medical Group 並不在名單上。</p>
</div><p>While Pediatrix Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Pediatrix Medical Group 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

PharVision Advisers LLC 在 Pediatrix Medical Group, Inc. (NYSE:MD) 中建立了 24.5 萬美元的頭寸